Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Scrip Team
As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.
Bristol-Myers Squibb is to give away more medicines to uninsured US patients, Cancer Research UK tells of funding hardship, Oxford Biomedica joins a consortium to rapidly develop a vaccine, while a Korean company works on a stem cell therapy.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Entries for the Scrip Awards are now open. Now in their 16th year, the Awards seek to reward the outstanding achievements of the pharmaceutical, biotech and allied industries in improving human health and will take place in London on 2 December.
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.